BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 21067275)

  • 1. Mucoadhesive hydrogel microparticles based on poly (methacrylic acid-vinyl pyrrolidone)-chitosan for oral drug delivery.
    Sajeesh S; Sharma CP
    Drug Deliv; 2011 May; 18(4):227-35. PubMed ID: 21067275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery.
    Sajeesh S; Vauthier C; Gueutin C; Ponchel G; Sharma CP
    Acta Biomater; 2010 Aug; 6(8):3072-80. PubMed ID: 20144748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.
    Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP
    J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface-functionalized polymethacrylic acid based hydrogel microparticles for oral drug delivery.
    Sajeesh S; Bouchemal K; Sharma CP; Vauthier C
    Eur J Pharm Biopharm; 2010 Feb; 74(2):209-18. PubMed ID: 19737614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR; Sharma CP
    J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
    Wittaya-areekul S; Kruenate J; Prahsarn C
    Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
    Sajeesh S; Sharma CP
    Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
    Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
    Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
    Kumar A; Lahiri SS; Singh H
    Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel polyelectrolyte complexes based on poly(methacrylic acid)-bis(2-aminopropyl)poly(ethylene glycol) for oral protein delivery.
    Sajeesh S; Sharma CP
    J Biomater Sci Polym Ed; 2007; 18(9):1125-39. PubMed ID: 17931503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(N-vinylcaprolactam-co-methacrylic acid) hydrogel microparticles for oral insulin delivery.
    Mundargi RC; Rangaswamy V; Aminabhavi TM
    J Microencapsul; 2011; 28(5):384-94. PubMed ID: 21736523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
    Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
    J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
    Quan JS; Jiang HL; Kim EM; Jeong HJ; Choi YJ; Guo DD; Yoo MK; Lee HG; Cho CS
    Int J Pharm; 2008 Jul; 359(1-2):205-10. PubMed ID: 18490120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide.
    Gavini E; Rassu G; Muzzarelli C; Cossu M; Giunchedi P
    Eur J Pharm Biopharm; 2008 Feb; 68(2):245-52. PubMed ID: 17574825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
    Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
    J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
    Zhang Y; Wei W; Lv P; Wang L; Ma G
    Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-responsive and enzymatically-responsive hydrogel microparticles for the oral delivery of therapeutic proteins: Effects of protein size, crosslinking density, and hydrogel degradation on protein delivery.
    Koetting MC; Guido JF; Gupta M; Zhang A; Peppas NA
    J Control Release; 2016 Jan; 221():18-25. PubMed ID: 26616761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly methacrylic acid-alginate semi-IPN microparticles for oral delivery of insulin: a preliminary investigation.
    Sajeesh S; Sharma CP
    J Biomater Appl; 2004 Jul; 19(1):35-45. PubMed ID: 15245642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication and caffeine release from Fe3O4/P(MAA-co-NVP) magnetic microspheres with controllable core-shell architecture.
    Di HW; Luo YL; Xu F; Chen YS; Nan YF
    J Biomater Sci Polym Ed; 2011; 22(4-6):557-76. PubMed ID: 21144259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of smart delivery system for ascorbic acid using pH-responsive P(MAA-co-EGMA) hydrogel microparticles.
    Lee E; Kim K; Choi M; Lee Y; Park JW; Kim B
    Drug Deliv; 2010 Nov; 17(8):573-80. PubMed ID: 20626233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.